This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.94% per year. These returns cover a period from January 1, 1988 through July 6, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
View All Zacks #1 Ranked Stocks
Zacks News
Alto Ingredients (ALTO) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Alto Ingredients (ALTO) delivered earnings and revenue surprises of -150.00% and 11.71%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Alto Ingredients (ALTO) Q3 Earnings Expected to Decline
by Zacks Equity Research
Alto Ingredients (ALTO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Alto Ingredients (ALTO) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Alto Ingredients (ALTO) closed the most recent trading day at $4.82, moving -1.83% from the previous trading session.
Central Garden & Pet (CENT) Solid on Buyouts & Digital Efforts
by Zacks Equity Research
Central Garden & Pet (CENT) banks on its robust business strategies. It is steadily advancing its digital capabilities and making wise acquisitions to boost growth.
The Zacks Analyst Blog Highlights: Lifetime Brands, Alto Ingredients, Party City Holdco, Prestige Consumer Healthcare and RCI Hospitality
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Lifetime Brands, Alto Ingredients, Party City Holdco, Prestige Consumer Healthcare and RCI Hospitality
Consumer Spending, Personal Income Continue to Rise: 5 Picks
by Ritujay Ghosh
The rise in consumer confidence in July proves that people are showing faith in the economy, making this an ideal time to invest in consumer discretionary stocks like RICK, ALTO, PRTY, LCUT and PBH.
Zacks.com featured highlights include: SunOpta, Rent-A-Center, Sterling Construction, Vertex Pharmaceuticals and Alto Ingredients
by Zacks Equity Research
Zacks.com featured highlights include: SunOpta, Rent-A-Center, Sterling Construction, Vertex Pharmaceuticals and Alto Ingredients
Bet on 5 Top-Ranked Stocks With Rising P/E
by Sanghamitra Saha
Inside the top-ranked stocks that can beat earnings estimates in their next releases.
Alto Ingredients (ALTO) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Alto Ingredients (ALTO) delivered earnings and revenue surprises of 80.00% and 24.74%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Factors Likely to Influence Alto's (ALTO) Fate in Q2 Earnings
by Zacks Equity Research
Alto's (ALTO) Q2 performance is likely to gain from continued demand for specialty alcohol and its transformational initiatives. However, higher input costs act as a woe.